HBCP Options Swing to 52-Week Low PCR on Earnings Day
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
HBCP heads into its Q3 earnings print today with options positioning at its most bullish point of the past year, even as short sellers have spent the past week moving the opposite direction.
The options shift is the most striking development since yesterday's preview. The put/call ratio has collapsed further to 0.25, the 52-week low, now more than four standard deviations below its 20-day mean of 1.40. That is a dramatic extension of the call-buying trend flagged yesterday, when the PCR had already dropped to 1.19. For a community bank with thin options volume, a move of this magnitude reflects concentrated positioning rather than broad market noise. The borrow market, by contrast, remains relaxed. Availability is exceptionally loose at over 5,000%, meaning there is far more capacity to short than anyone is using. Cost to borrow ticked up to 0.51% over the past week but stays near negligible in absolute terms. The lending market is not signalling stress.
Short sellers and options traders are reading this print differently. Short interest rose 42% in a week to 3.4% of free float, the fastest weekly build in recent memory, a position that has held as call buyers piled in on the other side. The two camps have reached the print in direct opposition. Among close peers, GSBC, CTBI and EQBK all gained between 1.2% and 1.7% on the week. HBCP slipped 0.7% over the same period, a modest lag that may partly explain why call buyers see relative value ahead of the number.
The bull case centres on loan growth re-accelerating toward 4-6% for the year and the bank's demonstrated commitment to the dividend. The FDIC call report data from ORTEX Alt Data adds two factual anchors to that view. Total deposits have risen for eight consecutive quarters, reaching $3.08 billion as of the April 2026 period. Net loans and leases set a record for any Q2 in the dataset's history at $2.75 billion. Neither dataset has yet been measured to lead the reported figures, so they describe the balance sheet trajectory rather than pointing to the specific print. Bears counter that the loan-to-deposit ratio already sits above the bank's own target range, competition is compressing both asset yields and funding costs, and the forward earnings growth score ranks in only the 23rd percentile of the universe.
The most recent analyst move of note came from Piper Sandler in April 2026, when the firm downgraded to Neutral with a $69 target, a level the stock has since traded through in both directions. With the shares at $65.78, the mean analyst target of $73 implies meaningful upside if the quarter reassures on net interest margin and credit quality. Today's print is a direct test of whether the deposit streak and record loan book translated into earnings momentum, or whether margin compression absorbed the volume gains.
Stocks in this article
See the live data behind this article on ORTEX.
Open HBCP on ORTEX →How this article was generated
- Generated
- 20 Oct 2026, 04:23
- Data as of
- 20 Oct 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.